Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Biotechnology company Zura Bio recently announced the official completion of its public offering totaling $144 million.

Biotechnology company Zura Bio recently announced the official completion of its public offering totaling $144 million.

老虎证券老虎证券2026/02/27 11:54
Show original
In this issuance, the underwriters fully exercised the over-allotment option, demonstrating strong market confidence in the company's development prospects. The injection of these funds will provide important support for Zura Bio to advance its innovative therapy research and development.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

EUR/USD: ECB hawks lag Fed – ING

FXStreet•2026/11/13 09:48
EUR/USD: ECB hawks lag Fed – ING

Goldman Sachs: Applied Materials (AMAT.US) Posts Solid Q4 Results, DRAM and Advanced Packaging to Drive Accelerated Growth by 2027

Goldman Sachs maintains its "Buy" rating on Applied Materials but lowers its 12-month target price from $670 to $580.

智通财经•2026/11/13 09:18
Goldman Sachs: Applied Materials (AMAT.US) Posts Solid Q4 Results, DRAM and Advanced Packaging to Drive Accelerated Growth by 2027